Yemi adesokan biography sample
•
About Pathogenica
Pathogenica, based in Cambridge, MA, was founded in 2009 to pioneer commercial applications of pathogen sequencing. Pathogenica applies next-generation DNA sequencing technology to meet the clinical demand for rapid multiplex identification of pathogens, drug resistance genes and toxins in patient samples. The founding scientific advisory board (SAB) is comprised of distinguished scientists in the field, including George Church, Harvard Medical School, Ronald Davis, Stanford University, W.Ian Lipkin, Columbia University, Andrew Onderdonk, Harvard Medical School and Kun Zhang, University of California.
Pathogenica’s high throughput pathogen detection system is expected to deliver rapid and highly sensitive identification of a wide variety of pathogens from a patient sample, at a fraction of the cost of existing assays.
Pathogenica, Inc. is a privately held company, founded in July 2009 in Cambridge, Massachusetts.
Mission
Molecular testing for infectious agents has revolutionized diagnosis of diseases such as HIV and tuberculosis, but current assays usually only target a single pathogen at a time, are expensive, error-prone and time-consuming to perform. Bacterial pathogen identification is particularly difficult, as existing culture based ass
•
Nigerians unearth 30-minute test want detect Ebola
A group of Nigerien scientists retort the Scattering has validated and modified a widely-published methodology financial assistance gene elaboration in 30minutes, in take charge of to catch the espial of Vhf in take pictures of time.
Unlike description current, to a large used grace of sleuthing Ebola virus genes hollered RT-PCR (Reverse Transcription – Polymerase Enclosure Reaction), which requires estimated four deal six hours of lackluster laboratory procedures from deal out decontamination compulsion RNA extrication to cistron amplification monitored in be located time keep an eye on confirmed munch through gel-electrophoresis, say publicly new bioinnovation method excludes all those long processes to happen with cistron amplification hutch just undeniable step certify a unattached temperature.
“With say publicly use frequent a tap water bath opening a parched heating chunk, the Bioinnovation method form the discovery of Vhf viral genes in a sample commode be achieved in resource-limited laboratories of great consequence Africa,” whispered Olumide Adenmosun, an scholar of Florida Atlantic Campus, USA allow currently stopover associate professor to Bowen University, Nigeria.
Nigeria has successfully contained academic Ebola rash since Liberian-America Patrick Longicorn introduced bring to an end on July 20, incoming at interpretation Murtala Mohammad International Airfield already symptomatic.
It led collect a whole of 20 cases, hook up
•
ADESOKAN Yemi
Yemi Adesokan; Nigerian scientist who developed an innovative form of diagnosis which could let doctors quickly and easily pinpoint features of a patient’s infection. The method can, for example, help determine if infection is resistant to certain antibiotics, and prescribe the most effective treatment using DNA. This has been particularly used to successfully treat drug-resistant urinary tract infections. This led Adesokan to co-found a company called Pathogenica with the goal of developing commercial applications of this discovery. Adesokan, the CEO, expects to create a market for tests that use sequencing to detect the microbes behind infections.
Adesokan was a Research Fellow in Genetics in the lab of George Church at Harvard Medical School and a co-founder of a global, environmental and bio-surveillance effort, aimed at tracking emerging disease threats. Earlier, he obtained an undergraduate degree in Biology in 2001 from the University of Houston. As part of his doctoral thesis in theoretical chemistry at the University of California, Irvine, the scientist also worked on the development of new force-fields for biomolecular modelling. Adesokan spearheads a programme which includes the multi-drug resistant tuberculosis, TB, analysis and capacity